The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
Open accessAbstract
Increasing evidence connects non-alcoholic fatty liver disease (NAFLD) to cardiovascular disease (CVD). The aim of this study is to assess whether and to what extent the excess risk of CVD is conferred by NAFLD in a meta-analysis. We systematically searched PubMed, EmBase, Web of Science, and Cochrane Library for reports published between 1965 and July 3, 2015. Studies that reported data on association between NAFLD and adverse cardiovascular events or mortality were included. Thirty-four studies (164,494 participants, 21 cross-sectional studies, and 13 cohort studies) were included. NAFLD was not associated with overall mortality (HR = 1.14, 95% CI: 0.99–1.32) and CVD mortality (HR = 1.10, 95% CI: 0.86–1.41). However, NAFLD was associated with an increased risk of prevalent (OR = 1.81, 95% CI: 1.23–2.66) and incident (HR = 1.37, 95% CI: 1.10–1.72) CVD. For some specific CVDs, NAFLD was associated with an increased risk of prevalent (OR = 1.87, 95% CI: 1.47–2.37) and incident (HR = 2.31, 95% CI: 1.46–3.65) coronary artery disease (CAD), prevalent (OR = 1.24, 95% CI: 1.14–1.36) and incident (HR = 1.16, 95% CI: 1.06–1.27) hypertension, and prevalent (OR = 1.32, 95% CI: 1.07–1.62) atherosclerosis. In conclusion, the presence of NAFLD is associated with an increased risk of major adverse cardiovascular events, although it is not related to mortality from all causes or CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
(2014) · Medical Entomology and Zoology · Cited by 17,633
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Targher, G., Byrne, C. D., Lonardo, A., Zoppini, G., & Barbui, C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.013 · Cited by 1,424
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 992
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O. F. W., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 925
Fatty Liver: A Novel Component of the Metabolic Syndrome
Kotronen, A., & Yki-Järvinen, H. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 797
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Lazo, M., & Clark, J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091978 · Cited by 736
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
Hamaguchi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1579 · Cited by 542
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
Harrison, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00622-1 · Cited by 482
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
Epidemiology and Natural History of NAFLD and NASH
Ong, J. P., & Younossi, Z. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.009 · Cited by 457
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Zenari, L., Cigolini, M., Falezza, G., & Arcaro, G. (2006) · Diabetes Care · doi:10.2337/dc06-0135 · Cited by 401
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Targher, G., Marra, F., & Marchesini, G. (2008) · Diabetologia · doi:10.1007/s00125-008-1135-4 · Cited by 378
Stepanova, M., & Younossi, Z. M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.12.039 · Cited by 352
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
Dunn, W., Xu, R., Wingard, D. L., Rogers, C., Angulo, P., Younossi, Z. M., & Schwimmer, J. B. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02034.x · Cited by 325
Stepanova, M., Rafiq, N., Makhlouf, H., Agrawal, R., Kaur, I., Younoszai, Z., McCullough, A., Goodman, Z., & Younossi, Z. M. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2743-5 · Cited by 301
Wong, V. W.-S., Wong, G. L.-H., Yip, G. W.-K., Lo, A. O.-S., Limquiaco, J., Chu, W. C.-W., Chim, A. M.-L., Yu, C.-M., Yu, J., Chan, F. K.-L., et al. (2011) · Gut · doi:10.1136/gut.2011.242016 · Cited by 296
Adams, L. A., Harmsen, S., St. Sauver, J. L., Charatcharoenwitthaya, P., Enders, F. B., Therneau, T., & Angulo, P. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.18 · Cited by 293
Non-Alcoholic Fatty Liver Disease in Older People
Frith, J., Day, C. P., Henderson, E., Burt, A. D., & Newton, J. L. (2009) · Gerontology · doi:10.1159/000235677 · Cited by 282
Hepatic steatosis is associated with an increased risk of carotid atherosclerosis
Völzke, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1848 · Cited by 248
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Pichiri, I., Sorgato, C., Zenari, L., & Bonora, E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.030 · Cited by 235
PARK, S. H., KIM, B. I., YUN, J. W., KIM, J. W., PARK, D. I., CHO, Y. K., SUNG, I. K., PARK, C. Y., SOHN, C. I., JEON, W. K., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03362.x · Cited by 198
Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease
Assy, N., Djibre, A., Farah, R., Grosovski, M., & Marmor, A. (2010) · Radiology · doi:10.1148/radiol.09090769 · Cited by 192
McKimmie, R. L., Daniel, K. R., Carr, J. J., Bowden, D. W., Freedman, B. I., Register, T. C., Hsu, F.-C., Lohman, K. K., Weinberg, R. B., & Wagenknecht, L. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02188.x · Cited by 189
Targher, G., Bertolini, L., Padovani, R., Poli, F., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01817.x · Cited by 173
Sung, K., Wild, S. H., & Byrne, C. D. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.009 · Cited by 156
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
VanWagner, L. B., Ning, H., Lewis, C. E., Shay, C. M., Wilkins, J. T., Carr, J. J., Terry, J. G., Lloyd‐Jones, D. M., Jacobs, D. R., & Carnethon, M. R. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.962 · Cited by 151
Intrahepatic Fat Accumulation and Alterations in Lipoprotein Composition in Obese Adolescents
Cali, A. M. G., Zern, T. L., Taksali, S. E., de Oliveira, A. M., Dufour, S., Otvos, J. D., & Caprio, S. (2007) · Diabetes Care · doi:10.2337/dc07-1088 · Cited by 142
Nonalcoholic fatty liver disease and cardiovascular risk
Misra, V. L., Khashab, M. A., & Chalasani, N. (2009) · Current Gastroenterology Reports · doi:10.1007/s11894-009-0008-4 · Cited by 140
Clinical association between non‐alcoholic fatty liver disease and the development of hypertension
Ryoo, J., Suh, Y. J., Shin, H. C., Cho, Y. K., Choi, J., & Park, S. K. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12643 · Cited by 139
Sung, K., Ryan, M. C., & Wilson, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.024 · Cited by 128
Choi, S.-Y., Kim, D., Kim, H. J., Kang, J. H., Chung, S. J., Park, M. J., Kim, Y. S., Kim, C. H., Choi, S. H., Kim, W. K., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.238 · Cited by 127
Huang, Y., Bi, Y., Xu, M., Ma, Z., Xu, Y. H., Wang, T., Li, M., Liu, Y., Lu, J., Chen, Y., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.252957 · Cited by 116
Association between nonalcoholic fatty liver disease and coronary artery disease
Arslan, U., Türkoğlu, S., Balcıoğlu, S., Tavıl, Y., Karakan, T., & Çengel, A. (2007) · Coronary Artery Disease · doi:10.1097/mca.0b013e3282583c0d · Cited by 110
Thakur, M. L., Sharma, S., Kumar, A., Bhatt, S. P., Luthra, K., Guleria, R., Pandey, R. M., & Vikram, N. K. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.005 · Cited by 106
Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification
Chen, C., Nien, C., Yang, C., & Yeh, Y. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0935-9 · Cited by 106
Petit, J., Guiu, B., Terriat, B., Loffroy, R., Robin, I., Petit, V., Bouillet, B., Brindisi, M., Duvillard, L., Hillon, P., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0541 · Cited by 104
Agarwal, A. K., Jain, V., Singla, S. K., Baruah, B. P., Arya, V., Yadav, R., & Singh, V. P. (2011) · PubMed · Cited by 85
Chiang, C.-H., Huang, C., Chan, W., Chen, J., & Leu, H. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.09.003 · Cited by 64
Ağaç, M. T., Korkmaz, L., Çavuşoğlu, İ. G., Karadeniz, A. G., Ağaç, S., Bektas, H., Erkan, H., Varol, M. O., Vatan, M. B., Acar, Z., et al. (2013) · Angiology · doi:10.1177/0003319713479155 · Cited by 58
Li, J., He, S., Liu, P., Luo, L., Zhao, L., & Xiao, Y. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-132 · Cited by 57
Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans
Choi, D. H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i38.6453 · Cited by 49
Targher, G., Pichiri, I., Zoppini, G., Trombetta, M., & Bonora, E. (2012) · PubMed · doi:10.3275/7875 · Cited by 43
İdilman, İ. S., Akata, D., Hazırolan, T., Erdoğan, B. D., Aytemir, K., & Karçaaltıncaba, M. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12172 · Cited by 36
Clinical Significance of Non-Alcoholic Fatty Liver Disease as a Risk Factor for Prehypertension
Ryoo, J., Ham, W. T., Choi, J., Kang, M. A., An, S. H., Lee, J., Shin, H. C., & Park, S. K. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.7.973 · Cited by 32
Ramanujam, V., Amutha, A., Anjana, R. M., Ranjit Unnikrishnan, I., Deepa, M., & Mohan, V. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0165 · Cited by 27
Josef, P., Ali, I., Ariel, P., Alon, M., & Nimer, A. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10083409 · Cited by 22
Chan, W., Tan, A. T. B., Vethakkan, S. R., Tah, P., Vijayananthan, A., & Goh, K. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.02.009 · Cited by 20
Wang, J., Chiu, W., Chen, R.-C., Chen, F., & Tung, T. (2013) · Asia Pacific Journal of Public Health · doi:10.1177/1010539513483830 · Cited by 17
Cited by
Non-alcoholic fatty liver disease
Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
Simon, T. G., Roelstraete, B., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021) · Gut · doi:10.1136/gutjnl-2020-322786 · Cited by 673
Mantovani, A., Csermely, A., Petracca, G., Beatrice, G., Corey, K. E., Simon, T. G., Byrne, C. D., & Targher, G. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00308-3 · Cited by 674
Metadata
- Authors
- Wu, S., Wu, F., Ding, Y., Hou, J., Bi, J., & Zhang, Z.
- Venue
- Scientific Reports
- Published
- 2016-09-16
- Volume
- 6
- Issue
- 1
- Pages
- 33386-33386
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2519289952
- Cited by
- 318
- References
- 67
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.